01351nas a2200229   4500000000100000008004100001260004400042653001600086653002500102653002200127100001700149700001100166700001300177700001200190700001200202245015900214856008700373300000600460490000700466520063400473022001401107       2025                            d  bSpringer Science and Business Media LLC10aDoxycycline10aLymphatic filariasis10aHygiene protocols1 aKakakhel MZJ1 aRath S1 aSheraz M1 aRathi D1 aAhmed R00aTime to consider doxycycline in the standard treatment of lymphatic filariasis? Emerging evidence on use of doxycycline as an adjunct to hygiene protocols  uhttps://tropmedhealth.biomedcentral.com/counter/pdf/10.1186/s41182-025-00726-4.pdf  a30 v533 a<p>With lymphatic filariasis being a rampant condition in tropical countries, multiple treatment modalities are being explored for their efficacy and practicability of use in low resource settings. Doxycycline, a commonly available drug across the world, has been proposed to improve patient status in those suffering with lymphatic filariasis. In conjunct with hygiene protocols, emerging trials have highlighted the success of doxycycline as an add-on drug. In this letter, we highlight the major findings in recent trials, and the scope of integrating doxycycline into national elimination strategies against filariasis.</p>
  a1349-4147